A Moving Target
Proteins are dynamic, shape-shifting machines. Yet, most drug discovery tools treat them as static.
At PsiThera, we model biologically relevant protein motion to uncover hidden druggable states and design oral small molecules for disease targets long treated by injected biologics.
From Undrugged to Unlocked
Many high-value immunology targets lack chemical matter because druggable binding pockets appear minimally (or not at all) in static structures.
Our physics-native QUAISAR platform predicts when, where, and how these transient states emerge, opening new paths for oral small-molecule therapies where none previously existed.
